FurNavi connects every step of your pet's care journey — daily health, consultations, clinical procedures, regenerative medicine support, follow-up and outcome — with AI clinical navigation for veterinarians and RWE that moves the industry forward.
Guided by "One Patient, One Workspace", clinical workflow and AI navigation live in the same workspace — no standalone AI tools.
Workflow First, AI Second — clinical workflow first, AI as decision support
From clinical workflow to real-world evidence, every treatment leaves a traceable data trail.
Symptom triage, specialty routing, indication matching (OA / CKD intervention timing) and real-time optimization — decision support that never replaces professional judgment.
Explore the AI funnel →The Health Passport integrates life history and care records, giving pet parents and veterinarians the same health view — never losing continuity from daily care to clinical follow-up.
Meet the Health Passport →Workflow First: cases, treatments and follow-ups in one place, returning documentation to the rhythm of clinical care.
Learn about the workflow →Structured cases and Outcome Registry with 15 performance indicators tracking care results continuously.
Learn about the Outcome Registry →De-identified real-world evidence becomes an R&D asset: 1,000 cases for first-mover value, 12,000 cases as an IND accelerator, 90%+ data license gross margin.
Understand the RWE value →RBAC role permissions, multi-tenant data isolation, aligned with the Regenerative Medicine Act and GTP compliance direction.
Learn about the security architecture →Device acquisition, platform revenue, data accumulation, R&D conversion — a sustainable clinical data flywheel.
Diagnostic devices enter the clinic and immediately create digital records and follow-up data — the first entry point of the platform.
Clinical workflow + AI navigation + Health Passport, generating recurring revenue through subscriptions and service fees.
Real-world evidence supports veterinary drug and regenerative medicine development, shortening clinical development cost and time.
Built around the "first-mover advantage": early clinics deploy AI clinical navigation and share RWE data asset value first.
First-wave clinics
Regional network
12,000 cases
Island-wide network
Regulatory environment: per the BAPHIQ official interpretation (Letter No. 1131862817) and the Regenerative Medicine Act direction, the GTP compliance window leaves a 3–5 year market gap — early movers gain the time advantage.
Book a Clinic Visit Understand RWE ValueRWE is FurNavi's ultimate strategic asset: every de-identified dataset on the platform accelerates drug development and licensing.
At 1,000 RWE cases, the dataset becomes valuable for initial licensing and publication — Star Program clinics share the benefits first.
12,000 structured clinical cases can save 40–60% of clinical development cost and shorten the pre-IND phase for veterinary drugs and regenerative medicine.
Parent company Miracle Biomedical received FDA IND for its MSC frailty therapy in June 2026 (dual filing) — validating the group's regenerative medicine capability.
Regenerative medicine, Health Passport and AI clinical navigation — continuously updated.
MSC, exosomes and PRP fundamentals, plus how AI digital tracking integrates into practice.
Read more →From vaccine reminders to chronic disease tracking — one shared health view for owners and vets.
Read more →From symptom triage to outcome tracking — the path of AI decision support in practice.
Read more →Whether you are a veterinary clinic, pet parent or investor — let's step into the future of AI clinical navigation together.
Book a Demo Browse the Store